Enzo Biochem, Inc. operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzo Biochem with three other companies in this sector in the United States: Veracyte Inc (2018 sales of $92.01 million of which 100% was Development and commercialization), CareDx Inc ($76.57 million of which 79% was Service), and Psychemedics Corporation ($42.67 million of which 92% was Testing).

Sales Analysis. During the year ended July of 2018, sales at Enzo Biochem were $104.71 million. This is a decrease of 2.9% versus 2017, when the company's sales were $107.80 million. Contributing to the drop in overall sales was the 3.4% decline in Clinical Labs, from $77.41 million to $74.78 million. There were also decreases in sales in Life Sciences (down 1.5% to $29.94 million) .